ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology. The companys product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant ovarian cancer; IMGN529, an ADC that is in Phase 1b/2 clinical trials for B-cell malignancies; coltuximab ravtansine, which is in Phase 2 trials for B-cell malignancies; IMGN779 that is in Phase 1 clinical trials for the treatment of acute myeloid leukemia (AML); and IMGN632, a preclinical CD123-targeting ADC for the treatment of hematological malignancies, including AML. ImmunoGen, Inc. has collaborations with Roche; Bayer HealthCare AG; Sanofi; Biotest AG; Novartis Institutes for BioMedical Research, Inc.; Eli Lilly and Company; Amgen; Takeda Pharmaceutical Company Limited; Merck; and CytomX Therapeutics, Inc. ImmunoGen, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts. O/S =89.35M Float = 81.09M Institutions = 91.70% ImmunoGen Presents Data from Phase I Study of IMGN779 in Acute Myeloid Leukemia - https://finance.yahoo.com/news/immunogen-presents-data-phase-study-120000335.html Was posting about this one in daily thread - has been a great play from the $4's. Sold last week after it broke $6 and then bought more on dip and expected more of move this morning on news BUT took all day for it to finally take off. Overbought territory and expect another pull before next move up.
^^ uh-oh can't remember who it was but someone else posted in the daily that s/he was playing this in the $2's too so is there a thread here somewhere that i missed? And you are right, it has been a tear and since the $4's for me BUT selling on news so may be going back down to the $2's (j/k) - noticed 3 block sells @ 200+k around close so someone is unloading.
Ive had it in my sights for a while! I actually bought it somewhere around $3.50.... buuuuuut then i sold it and took a loss on that big dip
Price target raised to $9. https://www.streetinsider.com/Analy...Management+Meetings+-+Jefferies/13056862.html
On the move again - stock is so predictable (at least for right now) - nice move from under $7 but RSI still too high.
Looks like it broke down out of a steep up channel and couldn't quite make it back in Id look for a top to form here
^^ Agree - have been expecting/waiting on another pull back & was surprised by pm/today's activity but don't mind it either!
This little energizer bunny being up a/h had me taking a closer look at chart and looks like this may not be pulling back under $7 again but tomorrow (sell day) will tell the story... Last year shows pretty good support around $7.50 ish & dipped to around this level a couple times today before bouncing up to resistance area, and looks like it may be working on filling a little gap between $7.25ish - $8.40'ish..
PT = $12 >> ImmunoGen's Turnaround Is 'In Full-Swing' Following ASCO Presentations - https://www.benzinga.com/analyst-ra...ampaign=Feed:+benzinga/news+(Channels+-+News)
looks like it may have hit bottom this morning & has been bouncing back up against $6.80's all day long so might wanna keep on radar.
